The tumor necrosis factor-α promoter correlates with progression of primary biliary cirrhosis

Journal of Hepatology

Volumn 30, Issue 5, 1999, Pages 826-829

  Tanaka, Atsushi ^a   Quaranta, Stefano ^a   Mattalia, Alberto ^b   Coppel, Ross ^c   Rosina, Floriano ^b   Manns, Michael ^d   Gershwin, M Eric ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b MOLINETTE HOSPITAL   (Italy)

^c MONASH UNIVERSITY   (Australia)

^d HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Cholestasis; Primary biliary cirrhosis; TNF ; Transplantation

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA;

ALLELE; ARTICLE; CHOLESTASIS; CONTROLLED STUDY; CORRELATION FUNCTION; DISEASE COURSE; DNA POLYMORPHISM; GENE FREQUENCY; GENETIC SUSCEPTIBILITY; HUMAN; MAJOR CLINICAL STUDY; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; PROGNOSIS; PROMOTER REGION;

EID: 0033054811     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(99)80135-4     Document Type: Article

References (42)

1. Leung PSC, Coppel RL, Ansari A, Munoz S, Gershwin ME. Antimitochondrial antibodies in primary biliary cirrhosis. Semin Liver Dis. 17:1997;61-69.
2. Bach N, Schaffer F. Familial primary biliary cirrhosis. J Hepatol. 20:1994;698-701.
3. Brind AM, Bray GP, Portmann BC, Williams R. Prevalence and pattern of familial disease in primary biliary cirrhosis. Gut. 36:1995;615-617.
4. Morling N, Dalhoff K, Fugger L, Georgsen J, Jakobson B, Ranek L, et al. DNA polymorphism of HLA class II genes in primary biliary cirrhosis. Immunogenetics. 35:1992;112-116.
5. Prochazka EJ, Terasaki PI, Park MS, Goldstein LI, Busuttil RW. Association of primary sclerosing cholangitis with HLA-DRw52a. N Engl J Med. 322:1990;1842-1844.
6. Manns MP, Bremm A, Schenider PM, Notghi A, Gerken G, Prager-Eberle M, et al. HLA DRw8 and complement C4 deficiency as risk factors in primary biliary cirrhosis. Gastroenterology. 101:1991;1367-1373.
7. Gregory WL, Mehal W, Dunn AN, Cavanagh G, Chapman R, Fleming KA, et al. Primary biliary cirrhosis: contribution of HLA class II allele DR8. Q J Med. 86:1993;393-399.
8. Mehal WZ, Gregory WL, Dennis Lo Y-M, Cross SJ, Fleming KA, Bassendine MF, et al. Defining the immunogenetic susceptibility to primary biliary cirrhosis. Hepatology. 20:1994;1213-1219.
9. *0402 haplotype. Hepatology. 16:1992;1404-1408.
10. Begovich AB, Klitz W, Moonsamy PV, Van de Water J, Peltz G, Gershwin ME. Genes within the HLA class II region confer both predisposition and resistance to primary biliary cirrhosis. Tissue Antigens. 43:1994;71-77.
11. *0301 in a German population. Hepatology. 21:1995;398-402.
12. Vassali P. The pathophysiology of tumor necrosis factor. Annu Rev Immunol. 10:1992;411-452.
13. Trowsdale J, Ragoussis J, Campbell RD. Map of the human MHC. Immunol Today. 12:1991;443-446.
14. Wilson AG, di Giovine FS, Blakemore AIF, Duff GW. Single base polymorphism in the human tumour necrosis factor alpha (TNF-α) gene detectable by Ncol restriction of PCR product. Hum Mol Genet. 1:1992;353.
15. Kroeger KM, Abraham LJ. Identification of an AP-2 element in the -323 to -285 region of the TNF-alpha gene. Biochem Mol Biol Int. 40:1996;43-51.
16. Wilson AG, Symons JA, McDowell TL, McDevitt HO, Duff GW. Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc Natl Acad. 94:1997;3195-3199.
17. Wu WS, McClain KL. DNA polymorphisms and mutations of the tumor necrosis factor-alpha (TNF-α) promoter in Langerhans cell histiocytosis (LCH). J Interferon Cytokine Res. 17:1997;631-635.
18. Kroeger KM, Carvill KS, Abraham LJ. The -308 tumor necrosis factor-alpha promoter polymorphism effects transcription. Mol Immunol. 34:1997;391-399.
19. Wilson AG, Gordon C, di Giovine FS. A genetic association between systemic lupus erythematosus and tumour necrosis factor alpha. Eur J Immunol. 24:1994;191-195.
20. Bouma G, Xia B, Crusius JB. Distribution of four polymorphisms in the tumour necrosis factor (TNF) genes in patients with inflammatory bowel disease. Clin Exp Immunol. 103:1996;391-396.
21. Mascher B, Schmitt W, Csernok E, Tatsis E, Reil A, Gross WL, et al. Polymorphisms in the tumor necrosis factor genes in Wegener's granulomatosis. Exp Clin Immunogenet. 14:1997;226-233.
22. Sullivan KE, Wooten C, Schmeckpeper BJ, Goldman D, Petri MA. A promoter polymorphism of tumor necrosis factor alpha associated with systemic lupus erythematosus in African-Americans. Arthritis Rheum. 40:1997;2207-2211.
23. Moffatt MF, Cookson WO. Tumour necrosis factor haplotypes and asthma. Hum Mol Genet. 6:1997;551-554.
24. Albuquerque RV, Hayden CM, Palmer LJ, Laing IA, Rye PJ, Gibson NA, et al. Association of polymorphisms within the tumour necrosis factor (TNF) genes and childhood asthma. Clin Exp Allergy. 28:1998;578-584.
25. McGuire W, Hill AVS, Allsopp CEM, Greenwood BM, Kwlatkowski D. Variation in the TNF-alpha promoter region associated with susceptibility to cerebral malaria. Nature. 371:1994;508-511.
26. Cabrera M, Shaw M-A, Sharples C. Polymorphism in tumor necrosis factor genes associated with mucocutaneous leishmaniasis. J Exp Med. 182:1995;1529-1564.
27. Manus RM, Wilson AG, Mansfield J, Weir DG, Duff GW, Kelleher D. TNF2, a polymorphism of the tumour necrosis-alpha gene promoter, is a component of the celiac disease major histocompatibility complex haplotype. Eur J Immunol. 26:1996;2113-2118.
28. Huang SL, Su CH, Chang SC. Tumor necrosis factor-alpha gene polymorphism in chronic bronchitis. Am J Respir Crit Care Med. 156:1997;1436-1439.
29. Roy S, McGuire W, Mascie-Taylor CG, Saha B, Hazra SK, Hill AV, et al. Tumor necrosis factor promoter polymorphism and susceptibility to lepromatous leprosy. J Infect Dis. 176:1997;530-532.
30. Seitzer U, Swider C, Stuber F, Suchnicki K, Lange A, Richter E, et al. Tumour necrosis factor alpha promoter gene polymorphism in sarcoidosis. Cytokine. 9:1997;787-790.
31. Conway DJ, Holland MJ, Bailey RL, Campbell AE, Mahdi OS, Jennings R, et al. Scarring trachoma is associated with polymorphism in the tumor necrosis factor alpha (TNF-α) gene promoter and with elevated TNF-α levels in tear fluid. Infect Immun. 65:1997;1003-1006.
32. Dickson ER, Grambsch PM, Fleming TR, Fisher LD, Langworthy A. Prognosis in primary biliary cirrhosis: model for decision making. Hepatology. 10:1989;1-7.
33. Brinkman BMN, Zuijdgeest D, Kaijzel EL, Breedveld FC, Verweij CL. Relevance of the tumor necrosis factor alpha (TNF-α) -308 promoter polymorphism in TNF-α gene regulation. J Inflamm. 46:1996;32-41.
34. Miller LC, Kaplan MM. Serum interleukin-2 and tumor necrosis factor-α in primary biliary cirrhosis: decrease by colchicine and relationship to HLA-DR4. Am J Gastroenterol. 87:1992;465-470.
35. Pukel C, Baquerizo H, Rabinovitch A. Destruction of rat islet cell monolayers by cytokines. Synergistic interactions of interferon-gamma, tumor necrosis factor, lymphotoxin and interleukin-1. Diabetes. 37:1998;133-136.
36. Ruddle NH, Bergman CM, McGrath KM, Lingenheld EG, Grunnet ML, Padula SJ, et al. An antibody to lymphotoxin and tumor necrosis factor prevents transfer of experimental allergic encephalitis. J Exp Med. 172:1990;1193-1200.
37. Dayer J-M, Beutler B, Cerami A. Cachectin/tumor necrosis factor stimulates collagenase and prostaglandin E2 production by human synovial cells and dermal fibroblasts. J Exp Med. 162:1985;163-168.
38. Mauviel A, Daireaux M, Redini F, Galera P, Loyau G, Pujol J-P. Tumor necrosis factor inhibits collagen and fibronectin synthesis in human dermal fibroblasts. FEBS Lett. 236:1988;47-52.
39. Solis-Herruzo JA, Brenner DA, Chojker M. Tumor necrosis factor-α inhibits collagen gene transcription and collagen synthesis in cultured human fibroblasts. J Biol Chem. 263:1988;5841-5845.
40. Rapala K, Peltonen J, Heino J, Kujari H, Pupol J-P, Niinikoski J, et al. Tumor necrosis factor-α selectively modulates expression of collagen genes in rat granulation tissue. Eur J Surg. 163:1997;207-214.
41. Nakanuma Y, Tsuneyama K, Gershwin ME, Yasoshima M. Pathology and immunopathology of primary biliary cirrhosis with emphasis on bile duct lesions: recent progress. Semin Liver Dis. 15:1995;313-328.
42. Wilson AG, de Vries N, Pociot F, di Giovine FS, van der Putte LBA, Duff GW. An allelic polymorphism within the human tumor necrosis factor alpha promoter region is strongly associated with HLA A1, B8, and DR3 alleles. J Exp Med. 177:1993;557-560.